A. Kathleen McClendon

2.1k total citations
20 papers, 1.6k citations indexed

About

A. Kathleen McClendon is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, A. Kathleen McClendon has authored 20 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 14 papers in Molecular Biology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in A. Kathleen McClendon's work include Cancer-related Molecular Pathways (10 papers), Cancer therapeutics and mechanisms (7 papers) and Advanced Breast Cancer Therapies (5 papers). A. Kathleen McClendon is often cited by papers focused on Cancer-related Molecular Pathways (10 papers), Cancer therapeutics and mechanisms (7 papers) and Advanced Breast Cancer Therapies (5 papers). A. Kathleen McClendon collaborates with scholars based in United States, Australia and Denmark. A. Kathleen McClendon's co-authors include Neil Osheroff, Erik S. Knudsen, Jeffry L. Dean, Chris Reed, Chellappagounder Thangavel, Agnieszka K. Witkiewicz, Armando C. Rodriguez, Lisa M. Butler, Wayne D. Tilley and Theresa E. Hickey and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Molecular Cell.

In The Last Decade

A. Kathleen McClendon

20 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A. Kathleen McClendon United States	17	937	904	607	202	175	20	1.6k
Richard Woessner United States	20	738 0.8×	1.2k 1.3×	91 0.1×	103 0.5×	137 0.8×	45	1.6k
Douglas Bootle Switzerland	13	582 0.6×	718 0.8×	304 0.5×	150 0.7×	86 0.5×	17	1.2k
Victoria J. Spanswick United Kingdom	21	462 0.5×	914 1.0×	94 0.2×	258 1.3×	267 1.5×	39	1.3k
James V. Alvarez United States	21	1.1k 1.2×	1.1k 1.2×	636 1.0×	482 2.4×	47 0.3×	36	2.1k
Murray J. Towle United States	17	509 0.5×	440 0.5×	95 0.2×	119 0.6×	211 1.2×	24	1.1k
Morten Grauslund Denmark	21	464 0.5×	848 0.9×	333 0.5×	203 1.0×	56 0.3×	44	1.4k
Meilan Liu United States	18	575 0.6×	995 1.1×	292 0.5×	427 2.1×	76 0.4×	46	1.6k
Franklin C. Harwood United States	16	547 0.6×	919 1.0×	168 0.3×	144 0.7×	84 0.5×	17	1.4k
Yi Jer Tan China	13	373 0.4×	694 0.8×	163 0.3×	260 1.3×	198 1.1×	24	1.4k
Takashi Kobunai Japan	23	727 0.8×	621 0.7×	213 0.4×	262 1.3×	130 0.7×	60	1.4k

Countries citing papers authored by A. Kathleen McClendon

Since Specialization

Citations

This map shows the geographic impact of A. Kathleen McClendon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Kathleen McClendon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Kathleen McClendon more than expected).

Fields of papers citing papers by A. Kathleen McClendon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Kathleen McClendon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Kathleen McClendon. The network helps show where A. Kathleen McClendon may publish in the future.

Co-authorship network of co-authors of A. Kathleen McClendon

This figure shows the co-authorship network connecting the top 25 collaborators of A. Kathleen McClendon. A scholar is included among the top collaborators of A. Kathleen McClendon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Kathleen McClendon. A. Kathleen McClendon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Knudsen, Erik S., A. Kathleen McClendon, Jorge Franco, et al.. (2015). RB loss contributes to aggressive tumor phenotypes in MYC-driven triple negative breast cancer. Cell Cycle. 14(1). 109–122. 34 indexed citations

Comstock, Clay E.S., Michael A. Augello, Jonathan F. Goodwin, et al.. (2013). Targeting cell cycle and hormone receptor pathways in cancer. Oncogene. 32(48). 5481–5491. 81 indexed citations

Dean, Jeffry L., A. Kathleen McClendon, Theresa E. Hickey, et al.. (2012). Therapeutic response to CDK4/6 inhibition in breast cancer defined by ex vivo analyses of human tumors. Cell Cycle. 11(14). 2756–2761. 182 indexed citations

McClendon, A. Kathleen, Jeffry L. Dean, Dayana B. Rivadeneira, et al.. (2012). CDK4/6 inhibition antagonizes the cytotoxic response to anthracycline therapy. Cell Cycle. 11(14). 2747–2755. 134 indexed citations

Dean, Jeffry L., A. Kathleen McClendon, & Erik S. Knudsen. (2012). Modification of the DNA Damage Response by Therapeutic CDK4/6 Inhibition. Journal of Biological Chemistry. 287(34). 29075–29087. 120 indexed citations

Knudsen, Erik S., et al.. (2012). Retinoblastoma and Phosphate and Tensin Homolog Tumor Suppressors: Impact on Ductal Carcinoma In Situ Progression. JNCI Journal of the National Cancer Institute. 104(23). 1825–1836. 16 indexed citations

Thangavel, Chellappagounder, Adam Ertel, A. Kathleen McClendon, et al.. (2011). RB Restricts DNA Damage-Initiated Tumorigenesis through an LXCXE-Dependent Mechanism of Transcriptional Control. Molecular Cell. 43(4). 663–672. 35 indexed citations

McClendon, A. Kathleen, Jeffry L. Dean, Adam Ertel, et al.. (2011). RB and p53 Cooperate to Prevent Liver Tumorigenesis in Response to Tissue Damage. Gastroenterology. 141(4). 1439–1450. 26 indexed citations

Dean, Jeffry L., Chellappagounder Thangavel, A. Kathleen McClendon, Chris Reed, & Erik S. Knudsen. (2010). Therapeutic CDK4/6 inhibition in breast cancer: key mechanisms of response and failure. Oncogene. 29(28). 4018–4032. 305 indexed citations

10.

Reed, Chris, Christopher N. Mayhew, A. Kathleen McClendon, et al.. (2009). RB has a critical role in mediating the in vivo checkpoint response, mitigating secondary DNA damage and suppressing liver tumorigenesis initiated by aflatoxin B1. Oncogene. 28(50). 4434–4443. 22 indexed citations

11.

McClendon, A. Kathleen, Jeffry L. Dean, Adam Ertel, & Erik S. Knudsen. (2009). Differential Impact of Tumor Suppressor Pathways on DNA Damage Response and Therapy-Induced Transformation in a Mouse Primary Cell Model. PLoS ONE. 5(1). e8558–e8558. 2 indexed citations

12.

Reed, Christopher A., Christopher N. Mayhew, A. Kathleen McClendon, & Erik S. Knudsen. (2009). Unique Impact of RB Loss on Hepatic Proliferation. Journal of Biological Chemistry. 285(2). 1089–1096. 13 indexed citations

13.

Dean, Jeffry L., A. Kathleen McClendon, Kristy R. Stengel, & Erik S. Knudsen. (2009). Modeling the effect of the RB tumor suppressor on disease progression: dependence on oncogene network and cellular context. Oncogene. 29(1). 68–80. 12 indexed citations

14.

McClendon, A. Kathleen, et al.. (2008). Bimodal Recognition of DNA Geometry by Human Topoisomerase IIα: Preferential Relaxation of Positively Supercoiled DNA Requires Elements in the C-Terminal Domain. Biochemistry. 47(50). 13169–13178. 54 indexed citations

15.

Frøhlich, Rikke, Félicie F. Andersen, A. Kathleen McClendon, et al.. (2007). Tryptophane-205 of human topoisomerase I is essential for camptothecin inhibition of negative but not positive supercoil removal. Nucleic Acids Research. 35(18). 6170–6180. 19 indexed citations

16.

McClendon, A. Kathleen & Neil Osheroff. (2007). DNA topoisomerase II, genotoxicity, and cancer. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 623(1-2). 83–97. 341 indexed citations

17.

McClendon, A. Kathleen & Neil Osheroff. (2006). The Geometry of DNA Supercoils Modulates Topoisomerase-Mediated DNA Cleavage and Enzyme Response to Anticancer Drugs. Biochemistry. 45(9). 3040–3050. 36 indexed citations

18.

McClendon, A. Kathleen, Jennifer S. Dickey, & Neil Osheroff. (2006). Ability of Viral Topoisomerase II To Discern the Handedness of Supercoiled DNA: Bimodal Recognition of DNA Geometry by Type II Enzymes. Biochemistry. 45(38). 11674–11680. 21 indexed citations

19.

McClendon, A. Kathleen, Armando C. Rodriguez, & Neil Osheroff. (2005). Human Topoisomerase IIα Rapidly Relaxes Positively Supercoiled DNA. Journal of Biological Chemistry. 280(47). 39337–39345. 132 indexed citations

20.

Sappal, Darshan S., A. Kathleen McClendon, James Fleming, et al.. (2004). Biological characterization of MLN944: A potent DNA binding agent. Molecular Cancer Therapeutics. 3(1). 47–58. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact